Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study

Korkmaz, Serdal; Dal, Mehmet; Berber, Ilhami; Sahin, Deniz; Dogu, Mehmet; Ayyildiz, Orhan; Nizam, Ilknur; Albayrak, Murat; Esen, Ramazan; Namdaroglu, Sinem; ŞENCAN, MEHMET; AKAY, OLGA; Hacioglu, Sibel; Yildirim, Rahsan; Eser, Ali; TOMBAK, ANIL; Pala, Cigdem; İLHAN, OSMAN

doi:10.1111/ggi.12341

Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study

Atıf İçin Kopyala

Korkmaz S., Dal M. S., Berber I., Sahin D. G., Dogu M. H., Ayyildiz O., ...Daha Fazla

GERIATRICS & GERONTOLOGY INTERNATIONAL, cilt.15, sa.6, ss.729-735, 2015 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 15 Sayı: 6
Basım Tarihi: 2015
Doi Numarası: 10.1111/ggi.12341
Dergi Adı: GERIATRICS & GERONTOLOGY INTERNATIONAL
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
Sayfa Sayıları: ss.729-735
Anahtar Kelimeler: chronic myeloid leukemia, dasatinib, elderly patients, imatinib, nilotinib, CHRONIC-PHASE, MYELOPROLIFERATIVE DISORDERS, 1ST-LINE TREATMENT, IMATINIB TREATMENT, CML, INTERFERON, RECOMMENDATIONS, CYTARABINE, MANAGEMENT, NILOTINIB
Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

AimsWe aimed to investigate whether older age leads to limitations in the starting dose of imatinib in daily treatment of chronic myeloid leukemia, and to determine the compliance of elderly patients with tyrosine kinase inhibitors (TKI) therapy.